SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Vineet Laboratories

BSE: 543298 28 Jun 2025
Healthcare
₹ 30
Vineet Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.

Vineet Laboratories - Share Price & Details

Market Cap
₹27.7
High /Low
78.5 / 25.4
Stock P/E
NA
Book Value
₹15.9
Dividend Yield
0.0
ROCE
-25.1
ROE
₹-81.8
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-4.69
Debt
40.0
CMP / FCF
-4.48
Debt to equity
₹2.73
NP Ann
-20.2
High price all time
125.0
Piotroski score
₹3.0
Graham Number
NA
No. Eq. Shares
0.92
Net CF
₹0.08
Net profit
-20.2
Price to book value
1.89
Interest Coverage
₹-4.22
Low price all time
25.4
Industry PE
33.8
Reserves
₹5.43
Free Cash Flow
₹10.4

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Vineet Laboratories Limited154.58-105.25140.76-11.4227.7
GENESIS IBRC INDIA LIMITEDNANANANA26.37.51
Adeshwar Meditex LimitedNANANANA26.312.7

Peer Comparison Chart


About Vineet Laboratories

Vineet Laboratories Limited, with Security Code 543298, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Vineet Laboratories Ltd Experiences Increased Buying Activity Amidst Market Volatility

(11 Jun 2025)
Vineet Laboratories Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, is experiencing strong buying activity despite a recent...
Read more →

VINEET LABORATORIES TO CONVENE BOARD MEETING

(09 Jun 2025)
Vineet Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2024.
Read more →

Has Vineet Laborator declared dividend?

(08 Jun 2025)
Yes, Vineet Laboratories Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of September 19, 2022. However, the company has...
Read more →

VINEET LABORATORIES TO CONDUCT BOARD MEETING

(24 May 2025)
Vineet Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2024.
Read more →

Vineet Laboratories Reports Declining Sales and Profitability Amid Operational Challenges in March 2025

(13 May 2025)
Vineet Laboratories has announced its financial results for the quarter ending March 2025, revealing operational challenges.
Read more →

Vineet Laboratories reports standalone net loss of Rs 10.53 crore in the March 2025 quarter

(13 May 2025)
Sales decline 62.00% to Rs 14.08 crore. Net loss of Vineet Laboratories reported to Rs 10.53 crore in the quarter ended March 2025 as against net profit of...
Read more →